MIC-135

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameMIC-135
Drug Alias NameMIC-135
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTyrosine-protein kinase receptor FLT3 inhibitorsInterleukin-15 stimulants
TargetsInterleukin-15Tyrosine-protein kinase receptor FLT3
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Hospital Tuebingen
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Hospital Tuebingen
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A